
无数据
无数据
无数据
| CAS Number | 74103-07-4 |
| Catalog Number | AG005TTC(AGN-PC-0JLUUO) |
| Chemical Name | Ketorolac tromethamine salt |
| IUPAC Name | 2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid |
| InChI | InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2 |
| InChI Key | BWHLPLXXIDYSNW-UHFFFAOYSA-N |
| MDL Number | MFCD00887595 |
| Molecular Formula | C19H24N2O6 |
| Molecular Weight | 376.4037 |
| NSC Number | 758637 |
| SMILES | O=C(C2C1=CC=C(C(C3=CC=CC=C3)=O)N1CC2)O.OCC(CO)(N)CO |
| Synonyms | Acular,
Ketorolac Tromethamine,
Toradol,
Ketorolac tromethamine,
Ketorolac tris salt,
74103-07-4,
Toradol,
Acular,
Acular LS,
Acular PF,
Ketorolac (tromethamine salt),
Ketorolac tromethamine salt,
Acuvail,
Syntex,
Ketorolac trometamol,
SPRIX,
Acular Preservative Free,
Ketorolac (Toradol),
Lixidol,
Dolac,
MFCD00887595,
2-amino-2-(hydroxymethyl)propane-1,3-diol 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate,
CPD000058461,
Toradol (TN),
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
Q-201269,
C19H24N2O6,
Godek,
(+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris salt,
CHEBI:6130,
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
2-amino-2-(hydroxymethyl)propane-1,3-diol; 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid,
SMR000058461,
Tromethamine ketorolac,
SR-01000075948,
RS-37619,
Toratex,
Droal,
Ketorolac Rinse,
Ketorolac tromethamine [USAN],
Tora-Dol,
Ketorolac tromethamine [USAN:USP],
2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid,
C15H13NO3.C4H11NO3,
Acular (TN),
BPPC,
ketorolac; tris buffer,
Spectrum_001578,
Ketorolac tromethamine ophthalmic solution,
Prestwick0_000929,
Prestwick1_000929,
Prestwick2_000929,
Prestwick3_000929,
Spectrum2_001598,
Spectrum3_001975,
Spectrum4_000215,
Spectrum5_001273,
ketorolac-tromethamine-salt,
AC1L36LM,
SCHEMBL5036,
Lopac0_000676,
BSPBio_000838,
BSPBio_003575,
KBioGR_000849,
KBioSS_002058,
Ketorolac tromethamine (USP),
MLS000069689,
MLS001401455,
MLS002222310,
DivK1c_000836,
SPECTRUM1503925,
SPBio_001596,
SPBio_003017,
BPBio1_000922,
CHEMBL1201124,
CTK8G0438,
HMS502J18,
KBio1_000836,
KBio2_002058,
KBio2_004626,
KBio2_007194,
KBio3_002953,
KS-00000XLJ,
ROX-828,
ROX-888,
BWHLPLXXIDYSNW-UHFFFAOYSA-N,
NINDS_000836,
Acular;Ketorolac tris salt;Toradol,
HMS1570J20,
HMS1922K22,
HMS2051P06,
HMS2093M05,
HMS2097J20,
HMS2235N13,
HMS3262G13,
HMS3373M06,
HMS3393P06,
HMS3655E15,
HMS3714J20,
Pharmakon1600-01503925,
BCP02917,
HY-B0138,
(+/-)-Ketorolac Tromethamine Salt,
Tox21_500676,
ABP001027,
BG0547,
CCG-39376,
CK0012,
NSC758637,
AKOS024386301,
API0003085,
BCP9000811,
CCG-101006,
CS-1933,
LP00676,
NC00256,
NSC-758637,
RL04801,
IDI1_000836,
NCGC00016159-02,
NCGC00016159-03,
NCGC00016159-04,
NCGC00094036-01,
NCGC00094036-02,
NCGC00094036-03,
NCGC00261361-01,
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+/-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol(1:1),
AN-37166,
AS-15193,
O440,
SAM001246596,
BCP0726000301,
Ketorolac tris salt, >=99%, crystalline,
AB2000191,
LS-139095,
EU-0100676,
FT-0630829,
K0053,
ST51037313,
SW197293-4,
D00813,
K 1136,
103K074,
C-21261,
SR-01000946595,
SR-01000075948-1,
SR-01000075948-6,
SR-01000075948-8,
SR-01000946595-1,
F0001-2390,
Ketorolac Trometamol 1.0 mg/ml in Methanol (as free acid),
Ketorolac trometamol, European Pharmacopoeia (EP) Reference Standard,
Ketorolac Tromethamine, United States Pharmacopeia (USP) Reference Standard,
Ketorolac trometamol for peak identification, European Pharmacopoeia (EP) Reference Standard,
Ketorolac Tromethamine, Pharmaceutical Secondary Standard; Certified Reference Material,
5-(phenylcarbonyl)-2,3-dihydropyrrolizinecarboxylic acid, 2-amino-2-(hydroxyme thyl)propane-1,3-diol,
Ketorolac Tris Salt / (+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic Acid Tris Salt,
ketorolac,
Exodol,
UNII-4EVE5946BQ,
4EVE5946BQ,
CID84003,
2600S,
C15-H13-N-O3.C4-H11-N-O3,
D020911,
|
| Complexity | 430 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 376.163g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 27 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 5 |
| Isotope Atom Count | 0 |
| Molecular Weight | 376.409g/mol |
| Monoisotopic Mass | 376.163g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 146A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H301-H315-H319-H335 |
| Packing Group | Ⅲ |
| Precautionary statements | P261-P301+P310-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

